Northern Ohio Neurosciences — Bellevue, Ohio

Northern Ohio Neurosciences is a clinical research site located in Bellevue, Ohio, United States 44811.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Northern Ohio Neurosciences has participated in 2 clinical trials.

Therapeutic areas: Epilepsy With Simple or Complex Partial Onset Seizures, Neuropathic Pain.

Sponsors: Sumitomo Pharma America, Inc., Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Bellevue

Browse all research sites in Ohio · View every site in Bellevue

• The Bellevue Hospital
• Research Site
• Northern Ohio Neuroscience, LLC
• Novartis Investigative Site
• Pfizer Investigational Site
• Insight Neuroscience LLC
• Merz Investigative Site # 001840
• Teva Investigational Site 10733
• Acorda Site #187
• Teva Investigational Site 10309

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northern Ohio Neurosciences?

Northern Ohio Neurosciences has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northern Ohio Neurosciences conducted?

Northern Ohio Neurosciences has 2 clinical trials on record. Their work covers Epilepsy With Simple or Complex Partial Onset Seizures, Neuropathic Pain.

Is Northern Ohio Neurosciences accredited by Crixeo Clinical Trials?

Northern Ohio Neurosciences has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northern Ohio Neurosciences?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.